Cite
HARVARD Citation
Shaw, P. et al. (n.d.). Genome Wide Analysis Reveals Host Genetic Variants that Associate with Reduction in Clostridium difficile Infection Recurrence (rCDI) in Patients Treated with Bezlotoxumab. Open forum infectious diseases. p. S380. [Online].